Congenital myasthenic syndromes

Seminars in Pediatric Neurology

Volumn 9, Issue 2, 2002, Pages 108-119

  Sieb, Joern P ^a,b   Kraner, Simone ^a,b   Steinlein, Ortrud K ^a,b  

^a MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

^b UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINESTERASE; CHOLINE ACETYLTRANSFERASE; CHOLINERGIC RECEPTOR; CHOLINERGIC RECEPTOR ANTIBODY; ANTIBODY;

APNEA; CHILDHOOD; DISEASE ASSOCIATION; ELECTROMYOGRAM; ENZYME DEFICIENCY; ENZYME SUBUNIT; HUMAN; INFANCY; MUSCLE WEAKNESS; MUTATION; MUTATIONAL ANALYSIS; MYASTHENIA GRAVIS; NEUROMUSCULAR TRANSMISSION; REVIEW; CONGENITAL MYASTHENIC SYNDROME; ELECTROMYOGRAPHY; ENZYMOLOGY; GENETICS; IMMUNOLOGY; METABOLISM; POINT MUTATION; SKELETAL MUSCLE;

ANTIBODIES; CHOLINE O-ACETYLTRANSFERASE; ELECTROMYOGRAPHY; HUMANS; MUSCLE, SKELETAL; MYASTHENIC SYNDROMES, CONGENITAL; POINT MUTATION; RECEPTORS, CHOLINERGIC;

EID: 0035996031     PISSN: 10719091     EISSN: None     Source Type: Journal    
DOI: 10.1053/spen.2002.33803     Document Type: Article

References (64)

1. 73rd ENMC international workshop: Congenital myasthenic syndromes. October 22-23. 1999, Naarden, The Netherlands
2. The investigation of congenital myasthenic syndromes
3. Acetylcholine receptor antibodies in juvenile myasthenia gravis
4. Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies
5. Myasthenia gravis: Quantitative immunocytochemical analysis of inflammatory cells and detection of complement membrane attack complex at the end-plate in 30 patients
6. Choline acetyl-transferase mutations cause myasthenic syndrome associated with episodic apnea in humans
7. Synaptic vesicle abnormality in familial infantile myasthenia
8. Familial infantile myasthenia: Confusion in terminology
9. Congenital myasthenic syndrome associated with paucity of synaptic vesicles and reduced quantal release
10. Congenital Lambert-Eaton myasthenic syndrome
11. Congenital myasthenic syndromes
12. Neuromuscular transmission in migraine: A single-fiber EMG study in clinical subgroups
13. Congenital endplate acetylcholinesterase deficiency
14. Human endplate acetylcholinesterase deficiency caused by mutations in the collagen-like tail subunit (ColQ) of the asymmetric enzyme
15. Treatment of 31 congenital myasthenic syndrome (CMS) patients with 3,4-diaminopyridine (DAP)
16. A common mutation (epsilon1267delG) in congenital myasthenic patients of Gypsy ethnic origin
17. Congenital myasthenic syndrome caused by decreased agonist binding affinity due to a mutation in the acetylcholine receptor ε subunit
18. Acetylcholine receptor δ subunit mutations underlie a fast-channel myasthenic syndrome and arthrogryposis multiplex congenita
19. A newly recognized congenital myasthenic syndrome attributed to a prolonged open time of the acetylcholine-induced ion channel
20. Quinidine sulfate in the treatment of the slow channel congenital myasthenic syndrome
21. Effects of the quinoline derivatives quinine, quinidine, and chloroquine on neuromuscular transmission
22. Quinidine sulfate therapy for the slow-channel congenital myasthenic syndrome
23. Congenital myasthenic syndromes due to heteroallelic nonsense/missense mutations in the acetylcholine receptor E subunit gene: Identification and functional characterization of six new mutations
24. Fundamental gating mechanism of nicotinic receptor channel revealed by mutation causing a congenital myasthenic syndrome
25. Myopathy, myasthenic syndrome, and epidermolysis bullosa simplex due to plectin deficiency
26. Congenital myasthenia associated with facial malformations in Iraqi and Iranian Jews: A new genetic syndrome
27. Single fiber EMG in a congenital myasthenic syndrome associated with facial malformations
28. Evidence for genetic heterogeneity supports clinical differences in congenital myasthenic syndromes
29. Familial limb-girdle myasthenia
30. Familial myasthenia with "tubular aggregates" treated with prednisone
31. Familial limb-girdle myasthenia with tubular aggregates
32. Neomutations in the collagenic tail subunit (ColQ) of acetylcholinesterase (AChE)
33. The spectrum of mutations causing end-plate acetylcholinesterase deficiency
34. Congenital end-plate acetylcholinesterase deficiency caused by a nonsense mutation and an A → G splice-donor-site mutation at position +3 of the collagenlike-tail-subunit gene (COLQ): How does G at position +3 result in aberrant splicing?
35. Mutation in the human acetylcholinesterase-associated collagen gene, COLQ, is responsible for congenital myasthenic syndrome with end-plate acetylcholinesterase deficiency (type Ic)
36. Unusual Congenital Myasthenic Syndrome (CMS) with endplate (EP) AChR deficiency caused by alpha subunit mutations and a remitting-relapsing clinical course
37. Acetylcholine receptor M3 domain: Stereochemical and volume contributions to channel gating
38. A novel fast-channel congenital myasthenic syndrome (CMS) caused by a mutation in the cys-loop domain of the acetylcholine receptor (AChR) subunit
39. Mutation causing congenital myasthenia reveals acetylcholine receptor β/δ subunit interaction essential for assembly
40. A newly identified N-box mutation of the acetylcholine receptor (AChR) epsilon gene promotor (ε- 154 → A) responsible for congenital myasthenic syndromes
41. Congenital myasthenic syndrome caused by a mutation in the Ets-binding, site of the promoter region of the acetylcholine receptor epsilon subunit gene
42. Mutation of the acetylcholine receptor ε-subunit promoter in congenital myasthenic syndrome
43. Myasthenic syndromes in Turkish kinships due to mutations in the acetylcholine receptor
44. Congenital myasthenic syndrome caused by prolonged acetylcholine receptor channel openings due to a mutation in the M2 domain of the ε subunit
45. Chromosome 17p-linked myasthenias stem from defects in the acetylcholine receptor epsilon-subunit gene
46. Identification and functional characterization of eight novel acetylcholine receptor (AChR) mutations in six congenital myasthenic syndrome (CMS) kinships
47. Immature end-plates and utrophin-deficiency in congenital myasthenic syndrome caused by ε-AChR subunit truncating mutations
48. Mutational analysis in a congenital myasthenic syndrome reveals a novel acetylcholine receptor epsilon-subunit mutation
49. Congenital myasthenic syndrome due to two novel mutations in the acetylcholine receptor epsilon-subunit gene
50. End-plate acetyl-choline receptor deficiency due to nonsense mutations in the? subunit
51. End-plate γ- and ε-subunit mRNA levels in AChR deficiency syndrome due to ε-subunit null mutations
52. Low-affinity fast-channel syndrome
53. Mode switching kinetics produced by a naturally occurring mutation in the cytoplasmic loop of the human acetylcholine receptor? subunit
54. Deletion of a single codon from the long cytoplasmic loop of the nAChR epsilon subunit gene causes brief single channel currents
55. Mutation of the acetylcholine receptor α subunit causes a slow-channel myasthenic syndrome by enhancing agonist binding affinity
56. Mutations in different functional domains of the human muscle acetylcholine receptor alpha subunit in patients with the slow-channel congenital myasthenic syndrome
57. New mutations in acetylcholine receptor subunit genes reveal heterogeneity in the slow-channel congenital myasthenic syndrome
58. Slow-channel mutations in the center of the M1 transmembrane domain of acetylcholine receptor (AChR) α? subunit
59. Slow-channel myasthenic syndrome caused by enhanced activation, desensitization, and agonist binding affinity attributable to mutation in the M2 domain of the acetylcholine receptor α subunit
60. A β-subunit mutation in the acetylcholine receptor channel gate causes severe slow-channel syndrome
61. Slow-channel congenital myasthenic syndrome (SCCMS) caused by a novel mutation in the acetylcholine receptor (AChR) [epsilon] sub-unit
62. Fundamental gating mechanism of nicotinic receptor channel revealed by mutation causing a congenital myasthenic syndrome
63. The nicotinic acetylcholine receptor of the Torpedo electric ray
64. Rapsyn mutations in humans cause endplate acetylcholine-receptor deficiency and myasthenic syndrome